Drug profile · INN
nafarelin acetate
SYNAREL
nafarelin acetate (SYNAREL) is a gonadotropin-releasing hormone receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
Drug details — nafarelin acetate
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nafarelin acetate (SYNAREL) is a gonadotropin-releasing hormone receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nafarelin acetate?
nafarelin acetate (SYNAREL) is a gonadotropin-releasing hormone receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for nafarelin acetate?
SYNAREL is a marketed brand name for nafarelin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nafarelin acetate?
nafarelin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.